Angelique Boerboom

Angelique Boerboom has a diverse work experience in various roles and companies. From 2017 to 2021, they worked as a Project Manager at EKLO, where they managed projects for four years. In 2020, they joined TEMAPAIN as a Financial and Marketing Manager until April 2021. Angelique then transitioned to a Board Member role at TEMAPAIN from May 2021 to December 2022. Currently, Angelique is working as a Project Manager at ExeVir, a clinical stage biotech company focused on developing antibody-based therapies for infectious diseases, with a particular emphasis on COVID-19. In this role, they coordinate activities across different departments and projects, handles fundraising and business development activities alongside the management team.

Angelique Boerboom obtained a University Certificate in Corporate Governance from HEC Liège Executive Education in 2017. Prior to that, they completed a PhD in Biomedical and Pharmaceutical Sciences at the University of Liège from 2012 to 2017. In addition, they earned a Master's degree in Management School from HEC Liège between 2014 and 2016. Angelique participated in an Erasmus program at the University of Aberdeen in 2010 and 2011, where they studied Biomedical Sciences. Angelique also holds a Master's degree in Biomedical Sciences from the University of Liège, which they received from 2007 to 2012.

Angelique Boerboom has obtained two additional certifications. In May 2019, they received the certification in Good Laboratory Practices, Quality Assurance and Control from CQHN asbl. Angelique also obtained the FELASA Category C certification for persons responsible for directing animal experiments from the Federation of European Laboratory Animal Science Associations in June 2013.